Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis

Lin,Hsin‑Chung; Lee,Herng‑Sheng; Chiueh,Tzong‑Shi; Lin,Yu‑Chieh; Lin,Hsin‑An; Lin,Yu‑Chun; Cha,Tai‑Lung; Meng,En

doi:10.3892/mmr.2014.3110

Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis

Authors:
- Hsin‑Chung Lin
- Herng‑Sheng Lee
- Tzong‑Shi Chiueh
- Yu‑Chieh Lin
- Hsin‑An Lin
- Yu‑Chun Lin
- Tai‑Lung Cha
- En Meng
View Affiliations

Affiliations: Department of Pathology, Tri‑Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan, R.O.C., Division of Infection, Department of Medicine, Tri‑Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan, R.O.C., Division of Urology, Department of Surgery, Tri‑Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan, R.O.C.
Published online on: December 18, 2014 https://doi.org/10.3892/mmr.2014.3110
Pages: 2421-2428
Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the current study was to evaluate the histopathological features of inflammation and the expression levels of inflammatory markers in tissue samples from patients with ketamine‑induced cystitis. Bladder biopsy samples for histological analysis were obtained from 23 patients (18 men and 5 women) with a self‑reported history of ketamine use and who were treated for cystitis at the Tri‑Service General Hospital of Taipei, Taiwan. Immunohistochemical staining for cyclooxygenase‑2 (COX‑2), inducible nitric oxide synthase (iNOS), matrix metallopeptidase‑9 (MMP‑9), mammalian target of rapamycin (mTOR), and phosphorylated 40S ribosomal protein S6 (Phos‑S6) was performed. The results revealed urothelial atypia in all patients, and intravascular eosinophil accumulation in 22 patients. Histopathological features included denuded urothelial mucosa, ulceration, collagen deposition, smooth muscle degeneration and vessel proliferation. Tissue samples were immunopositive for all of the inflammation markers, including the urothelium, vessel walls, and smooth muscle. COX‑2 staining revealed a significant difference between the inflammatory levels in the urothelium and smooth muscle, and iNOS staining differed significantly between inflammatory levels in smooth muscle (p=0.029). A positive correlation was observed between the percentage of Phos‑S6‑positive cells and the levels of inflammation in the urothelium. These results add to the descriptive literature on the histopathological aspects of ketamine‑induced cystitis, emphasizing the inflammatory nature and a possible role for proteins such as COX‑2, iNOS and Phos‑S6 in the degree of inflammation.

View Figures

View References

1	Domino EF, Chodoff P and Corssen G: Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther. 6:279–291. 1965.PubMed/NCBI
2	Sehdev RS, Symmons DA and Kindl K: Ketamine for rapid sequence induction in patients with head injury in the emergency department. Emerg Med Australas. 18:37–44. 2006. View Article : Google Scholar : PubMed/NCBI
3	Craven R: Ketamine. Anaesthesia. 62:48–53. 2007. View Article : Google Scholar : PubMed/NCBI
4	Bhutta AT: Ketamine: a controversial drug for neonates. Semin Perinatol. 31:303–308. 2007. View Article : Google Scholar : PubMed/NCBI
5	Corssen G and Domino EF: Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesth Analg. 45:29–40. 1966. View Article : Google Scholar : PubMed/NCBI
6	Lankenau SE and Sanders B: Patterns of ketamine use among young injection drug users. J Psychoactive Drugs. 39:21–29. 2007. View Article : Google Scholar : PubMed/NCBI
7	Chen CH, Lee MH, Chen YC and Lin MF: Ketamine-snorting associated cystitis. J Formos Med Assoc. 110:787–791. 2011. View Article : Google Scholar
8	Chen R, Lee AM and Chan R: A study on the cognitive impairment and other harmful effects from ecstasy and ketamine abuse. Hong Kong Chinese 2004. Narcotics Division, Security Bureau. The Government of the Hong Kong Special Administrative Region; 2004, http://www.nd.gov.hk/pdf/Study%20on%20the%20Cognitive%20Impairment%20and%20Other%20Harmful%20Effects%20Caused%20by%20Ketamine%20Abuse.pdf.
9	Chu PS, Kwok SC, Lam KM, et al: ‘Street ketamine’-associated bladder dysfunction: a report of ten cases. Hong Kong Med J. 13:311–313. 2007.PubMed/NCBI
10	Shahani R, Streutker C, Dickson B and Stewart RJ: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology. 69:810–812. 2007. View Article : Google Scholar : PubMed/NCBI
11	Wei YB, Yang JR, Yin Z, Guo Q, Liang BL and Zhou KQ: Genitourinary toxicity of ketamine. Hong Kong Med J. 19:341–348. 2013.PubMed/NCBI
12	Chu PS, Ma WK, Wong SC, et al: The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int. 102:1616–1622. 2008. View Article : Google Scholar : PubMed/NCBI
13	Chuang SM, Liu KM, Li YL, et al: Dual involvements of cyclooxygenase and nitric oxide synthase expressions in ketamine-induced ulcerative cystitis in rat bladder. Neurourol Urodyn. 32:1137–1143. 2013. View Article : Google Scholar : PubMed/NCBI
14	Mohammed MA, Seleim MF, Abdalla MS, Sharada HM and Abdel Wahab AH: Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer. BMC Urol. 13:252013. View Article : Google Scholar : PubMed/NCBI
15	Schultz L, Chaux A, Albadine R, et al: Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas. Am J Surg Pathol. 35:1549–1556. 2011. View Article : Google Scholar : PubMed/NCBI
16	Hansel DE, Platt E, Orloff M, et al: Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma. Am J Pathol. 176:3062–3072. 2010. View Article : Google Scholar : PubMed/NCBI
17	Makhlin I, Zhang J, Long CJ, et al: The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers. BJU Int. 108:E84–E90. 2011. View Article : Google Scholar :
18	Sappayatosok K, Maneerat Y, Swasdison S, et al: Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. Med Oral Patol Oral Cir Bucal. 14:E319–E324. 2009.PubMed/NCBI
19	Hu VY, Malley S, Dattilio A, Folsom JB, Zvara P and Vizzard MA: COX-2 and prostanoids expression in micturition pathways after cyclophosphamide-induced cystitis in the rat. Am J Physiol Regul Integr Comp Physiol. 284:R574–R585. 2003.
20	Xu X, Cubeddu LX and Malave A: Expression of inducible nitric oxide synthase in primary culture of rate bladder smooth muscle cells by plasma from cyclophosphamide-treated rats. Eur J Pharmacol. 416:1–9. 2001. View Article : Google Scholar : PubMed/NCBI
21	Chakrabarti S and Patel KD: Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res. 31:599–621. 2005. View Article : Google Scholar : PubMed/NCBI
22	Chaux A, Compérat E, Varinot J, et al: High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pT1 urothelial carcinoma of the bladder: a tissue microarray study of 156 patients treated by transurethral resection. Urology. 81:116–122. 2013. View Article : Google Scholar : PubMed/NCBI
23	Oxley JD, Cottrell AM, Adams S and Gillatt D: Ketamine cystitis as a mimic of carcinoma in situ. Histopathology. 55:705–708. 2009. View Article : Google Scholar : PubMed/NCBI